Financial statements L-Drog
Balance sheet data of L-DROG
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 2 511 814,40 | 2 335 920,53 | 2 380 670,33 | 2 684 895,53 | 3 383 015,34 | 4 116 869,07 |
| A. Fixed assets | 699 697,89 | 933 482,30 | 970 642,12 | 1 515 160,13 | 1 674 332,87 | 1 436 261,60 |
| B. Current assets | 1 812 116,51 | 1 402 438,23 | 1 410 028,21 | 1 169 735,40 | 1 708 682,47 | 2 680 607,47 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 2 511 814,40 | 2 335 920,53 | 2 380 670,33 | 2 684 895,53 | 3 383 015,34 | 4 116 869,07 |
| A. Equity | 1 849 025,55 | 1 892 331,99 | 1 793 192,79 | 2 003 655,16 | 2 106 573,71 | 2 463 263,15 |
| B. Liabilities and provisions for liabilities | 662 788,85 | 443 588,54 | 587 477,54 | 681 240,37 | 1 276 441,63 | 1 653 605,92 |
| I. Long-term liabilities | 50 000,00 | 50 000,00 | 175 764,58 | 230 704,21 | 243 761,22 | 209 715,30 |
| II. Short-term liabilities | 612 788,85 | 393 588,54 | 411 712,96 | 450 536,16 | 1 032 680,41 | 1 279 553,09 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.